Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Predictors of active injection drug use in a cohort of patients infected with hepatitis C virus.

Reed C, Bliss C, Stuver SO, Heeren T, Tumilty S, Horsburgh CR Jr, Samet JH, Cotton DJ.

Am J Public Health. 2013 Jan;103(1):105-11. doi: 10.2105/AJPH.2012.300819. Epub 2012 Nov 15.

2.

The association between hepatitis C virus and HIV-1 in preparatory cohorts for HIV vaccine trials in Thailand.

Paris R, Sirisopana N, Benenson M, Amphaiphis R, Tuntichaivanich C, Myint KS, Brown AE.

AIDS. 2003 Jun 13;17(9):1363-7.

PMID:
12799557
3.

Differences in hepatitis C virus prevalence and clearance by mode of acquisition among men who have sex with men.

Seaberg EC, Witt MD, Jacobson LP, Detels R, Rinaldo CR, Young S, Phair JP, Thio CL.

J Viral Hepat. 2014 Oct;21(10):696-705. doi: 10.1111/jvh.12198. Epub 2013 Nov 7.

4.
5.

Significant differences in clinical outcomes between HIV-hepatitis C virus coinfected individuals with and without injection drug use history.

Cescon A, Chan K, Raboud JM, Burchell AN, Forrest JI, Klein MB, Loutfy MR, Machouf N, Montaner JS, Tsoukas C, Hogg RS, Cooper C; CANOC Collaboration.

AIDS. 2014 Jan 2;28(1):121-7. doi: 10.1097/QAD.0000000000000020.

PMID:
24413263
6.
7.

Prevalence of hepatitis C in an ethnically diverse HIV-1-infected cohort in south London.

Mohsen AH, Murad S, Easterbrook PJ.

HIV Med. 2005 May;6(3):206-15.

8.

The future face of coinfection: prevalence and incidence of HIV and hepatitis C virus coinfection among young injection drug users.

Miller CL, Wood E, Spittal PM, Li K, Frankish JC, Braitstein P, Montaner JS, Schechter MT.

J Acquir Immune Defic Syndr. 2004 Jun 1;36(2):743-9.

PMID:
15167294
9.

Hospitalization rates differ by hepatitis C satus in an urban HIV cohort.

Gebo KA, Diener-West M, Moore RD.

J Acquir Immune Defic Syndr. 2003 Oct 1;34(2):165-73.

PMID:
14526205
10.

Hepatitis C virus coinfection in a cohort of HIV-infected individuals from Santos, Brazil: seroprevalence and associated factors.

Segurado AC, Braga P, Etzel A, Cardoso MR.

AIDS Patient Care STDS. 2004 Mar;18(3):135-43.

PMID:
15104874
11.

Frontloading: a risk factor for HIV and hepatitis C virus infection among injecting drug users in Berlin.

Stark K, Müller R, Bienzle U, Guggenmoos-Holzmann I.

AIDS. 1996 Mar;10(3):311-7.

PMID:
8882671
13.

High rate of hepatitis C virus (HCV) recurrence in HIV-infected individuals with spontaneous HCV RNA clearance.

Peters L, Mocroft A, Soriano V, Rockstroh JK, Kirkby N, Reiss P, Katlama C, Zakharova N, Flisiak R, Lundgren JD; EuroSIDA in EuroCoord.

HIV Med. 2014 Nov;15(10):615-20. doi: 10.1111/hiv.12160. Epub 2014 May 11.

14.

Incidence and correlates of hepatitis C virus infection in a large cohort of prisoners who have injected drugs.

Snow KJ, Young JT, Preen DB, Lennox NG, Kinner SA.

BMC Public Health. 2014 Aug 11;14:830. doi: 10.1186/1471-2458-14-830.

15.

Unsafe sex and increased incidence of hepatitis C virus infection among HIV-infected men who have sex with men: the Swiss HIV Cohort Study.

Rauch A, Rickenbach M, Weber R, Hirschel B, Tarr PE, Bucher HC, Vernazza P, Bernasconi E, Zinkernagel AS, Evison J, Furrer H; Swiss HIV Cohort Study.

Clin Infect Dis. 2005 Aug 1;41(3):395-402. Epub 2005 Jun 21.

PMID:
16007539
16.

Seroprevalence of hepatitis C and correlates of seropositivity among men who have sex with men in Vancouver, Canada: a cross-sectional survey.

Wong J, Moore D, Kanters S, Buxton J, Robert W, Gustafson R, Hogg R, Ogunnaike-Cooke S, Wong T, Gilbert M; ManCount Study Team.

Sex Transm Infect. 2015 Sep;91(6):430-3. doi: 10.1136/sextrans-2014-051928. Epub 2015 Apr 14.

PMID:
25872512
17.

Effect of exposure to injection drugs or alcohol on antigen-specific immune responses in HIV and hepatitis C virus coinfection.

Graham CS, Wells A, Edwards EM, Herren T, Tumilty S, Stuver SO, Samet JH, Nunes D, Horsburgh CR Jr, Koziel MJ.

J Infect Dis. 2007 Mar 15;195(6):847-56. Epub 2007 Feb 2.

PMID:
17299715
18.

A prospective study to examine persistent HCV reinfection in injection drug users who have previously cleared the virus.

Currie SL, Ryan JC, Tracy D, Wright TL, George S, McQuaid R, Kim M, Shen H, Monto A.

Drug Alcohol Depend. 2008 Jan 11;93(1-2):148-54. Epub 2007 Oct 30. Erratum in: Drug Alcohol Depend. 2008 Jul;96(1-2):192.

PMID:
17977668
19.

The investigation of HIV and HCV infection and risk factors among opiate drug users in Beijing, China.

Bao YP, Du C, Lu HY, Lian Z, Qiu Y, Mu Y, Yan SY, Liu ZM.

Am J Drug Alcohol Abuse. 2012 Mar;38(2):140-5. doi: 10.3109/00952990.2011.643984. Epub 2011 Dec 19.

PMID:
22175771
20.

HIV and hepatitis C coinfection within the CAESAR study.

Amin J, Kaye M, Skidmore S, Pillay D, Cooper DA, Dore GJ.

HIV Med. 2004 May;5(3):174-9.

Supplemental Content

Support Center